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Abstract: This study represents a comparison of the functional interrelation of fatigue and cognitive,
cardiovascular and autonomic nervous systems in a group of Chronic Fatigue Syndrome (CFS)
patients compared with those in healthy individuals at different stages of analysis: at baseline and
after changes induced by whole-body cryotherapy (WBC) combined with a static-stretching (SS)
program. The study included 32 patients (Fukuda criteria) and 18 healthy controls. Fatigue, cogni-
tive, cardiovascular and autonomic function and arterial stiffness were measured before and after
10 sessions of WBC with SS. In the patients, a disturbance in homeostasis was observed. The network
relationship based on differences before and after intervention showed comparatively higher stress
and eccentricity in the CFS group: 50.9 ± 56.1 vs. 6.35 ± 8.72, p = 0.002, r = 0.28; and 4.8 ± 0.7 vs.
2.4 ± 1, p < 0.001, r = 0.46, respectively. Before and after intervention, in the CFS group increased
fatigue was related to baroreceptor function, and baroreceptor function was in turn related to aortic
stiffness, but no such relationships were observed in the control group. Differences in the network
structure underlying the interrelation among the four measured criteria were observed in both groups,
before the intervention and after ten sessions of whole cryotherapy with a static stretching exercise.
Keywords: cold therapy; physical activity; stretching
1. Introduction
Whole body cryotherapy (WBC) has been proven to be a safe and efficient form of
physiotherapy in both sports medicine (e.g., skeletal disorders [1,2] and acute and chronic
injuries [3]) and clinical settings (e.g., fibromyalgia [4] and neurological disorders [4]).
WBC activates physiological mechanisms that maintain a constant core temperature. Acute
exposure to ambient cryotherapeutic temperatures is an extremely stressful stimulant that
induces rapid and short-term regulatory mechanisms predominantly associated with the
cardiovascular and autonomic nervous systems [5]. In addition, WBC programs have
been shown to improve immediate recall and orientation in older participants with mild
cognitive impairment and reduce fatigue in multiple sclerosis (MS) patients [6,7]. Pawik
et al. showed that WBC with physical training was more effective than WBC alone in
reducing depressive symptoms and improving functional status in MS patients [8].
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The influence of flexibility (stretching) exercises on cardiovascular and autonomic
nervous system responses has been explored [9–12]. The American College of Sports
Medicine (ACSM) describes flexibility as one of the most important components of physical
fitness [13]. Stretching is a non-pharmacological, low-intensity activity that can improve
vascular function for those with cardiovascular disorders and chronic fatigue disorders
and elicits a lower metabolic demand compared to moderate or vigorous aerobic exer-
cise [14–16]. Planned exercise therapy to strengthen weakened muscle or to increase joint
flexibility is often included as part of a treatment program for patients with chronic fatigue
and chronic fatigue syndrome (CFS), a common condition that remains difficult to diagnose
and manage. Some of the current challenges include an absence of diagnostic markers
and differing diagnostic criteria [17]. Post-exertional malaise (PEM) can be induced by
physical exercise in many CFS patients [18], so pacing is proposed as a method for man-
aging energy [19]. A stretching program characterized by relatively low intensity aerobic
or resistance exercise might be more effective in avoiding PEM. In their review Kruse
and Scheuermann described the unequivocal influence of acute and long-term stretch-
ing exercise responses on aortic stiffness, cardiovascular and autonomic nervous system
functioning, specifically an increase in parasympathetic and decrease in sympathetic ac-
tivity [20]. Therefore, it might be applied in CFS patients to treat secondary symptoms.
Autonomic nervous system (ANS) dysfunction is widely implicated as potentially under-
pinning CFS pathomechanisms [21]. Słomko et al. showed that patients with a sympathetic
profile (i.e., higher sympathetic activity at rest measured objectively) were characterized
by markedly low fatigue and subjective autonomic function, high objective autonomic
function and markedly high aortic stiffness. The parasympathetic profile (higher parasym-
pathetic activity at rest) showed a more severe disease with average subjective autonomic
function, low objective autonomic function levels and high arterial stiffness [22].
The 2015 Institute of Medicine (IOM) report highlighted an increasing body of liter-
ature citing cognitive impairment as a key symptom in people suffering from CFS [23].
One study noted a prevalence of 80% or more in brain fog/confusion, short-term mem-
ory problems, trouble concentrating, slow thinking, difficulty understanding/thinking
clearly and difficulty retaining information [24]. Between 50 and 85% of CFS patients noted
subjective cognitive impairment [25]. So-called brain fog includes a general slowdown in
response speed with tasks that require simple and complex information processing as well
as the ability to focus on a task [25]. Studies also confirmed that cognitive disturbances
are restricted to a decrease in basic processing speed, not to severity of depression [26,27].
Thayer and Lane promoted a neurovisceral integration model and underlined the con-
tribution of vagal heart rate variability (HRV) in the control of physiological, emotional
and cognitive processes. Low HRV is a risk factor for pathophysiology and psychopathol-
ogy [28]. Further studies have confirmed a correlation between cognitive and autonomic
nervous system function [29,30] and between autonomic nervous system function and
brain pathologies [31].
In summary, WBC with a stretching program might improve autonomic nervous
system function [5–7,20] A previous CFS study using a network analysis approach showed
evidence of disturbance glucose metabolism and in homeostasis in the autonomic nervous
and cardiovascular systems [32]. Thus, it seems that autonomic nervous system function,
cognitive function and aortic stiffness could be related to fatigue in CFS.
Allostasis is defined as the “process of maintaining homeostasis through the adap-
tive change of the organism’s internal environment to meet perceived and anticipated
demands” [33], and in the current study allostasis in CFS patients was compared to healthy
controls, before and in response to an intervention consisting of WBC and SS. The aim of
this study was to explore differences in the relationship among fatigue, autonomic nervous
system function, aortic stiffness and cognitive function in CFS compared to controls, both
before and in response to whole body cryotherapy and static stretching.
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2. Materials and Methods
2.1. Patients
Out of 250 individuals who identified themselves as fatigued, 32 patients with chronic
fatigue syndrome according to the Fukuda criteria were selected [34]. The inclusion criteria
for the study were men and women between 25 and 65 years, fatigued due to unknown
causes lasting for more than 6 months and at least four of the following additional symp-
toms: malaise after exertion, impaired memory or concentration, headache, unrefreshing
sleep, tender lymph nodes (cervical or axillary), sore throat, or muscle or joint pain. The
exclusion criterion was the presence of an illness that might trigger chronic fatigue (e.g., a
cardiovascular or autoimmune disease or a psychosocial cause). Patients could participate
in this study if they had been referred by a general practitioner, neurologist or psychiatrist.
A pre-test health assessment was carried out that included basic psychiatric and neurolog-
ical examinations. A consultant confirmed conformity with the inclusion and exclusion
criteria and determined whether an extensive physical examination or laboratory research
tests had been performed to exclude any underlying illness.
Eighteen healthy individuals were also recruited from the community as a control
group (HC). Thus, 32 CFSs and 18 HCs participated (Figure 1).
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2.2. Intervention—Whole otherapy (WBC) with a Static Stretching Exercise
The WBC procedures ere performed in a liquid nitrogen cryochamber consisting of
two compartments: an antechamber and a chamber proper, which were connected by a
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door. In the trial, the temperature in the antechamber was set at −60 ◦C, whereas in the
proper chamber, it reached −120 ◦C.
The participants were treated using a cycle of 10 visits over a period of 12 days (from
Monday to Friday, one session per day). They were subjected to the effects of extremely
low temperature in a WBC chamber for 0.5–2.5 min depending upon the day of therapy.
Exposure time was incremental: 1–3 days for 0.5 min, 4–5 days for 1 min, 6–7 days for
1.5 min, 8–9 days for 2 min and 10 days for 2.5 min (Figure 2).
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I e iatel after leaving, they underwent a static stretching exercise session
(Figure 3). According to ACSM recommendations for flexibility [13], our program in-
cluded static stretching of the major muscle tendon units of the shoulder girdle, chest, neck,
trunk, lower back, hips, posterior and anterior legs and ankles from small to large m scle
groups. Patients exercised in a lying position, gradually m ving to sitting standing.
Each stretch was held to the point of slight discomfort ( ot pain) for a period of 20 s p r
muscle group followed by 10 s passive rest period in a neutral position [35]. All sessions
of WBC and physical ex rcise w re carrie out under the supervision of a medical doctor
and experienced p ysiotherapists.
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ing to ACSM criteria [29].
2.3. Measures
The clinical examination was performed in the chronobiology laboratory (temper ture
22 ◦C, humidity 60%, windowless and sound-insulated) at approximately the same time
of day.
2.3.1. Fatigue Measurements
The Chalder Fatigue Questionnaire (CFQ), the Fa igue Severity Scale (FSS) and the
Fatigue Impact Scale (FIS) were used to evaluate severity.
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The Chalder Fatigue Questionnaire consisted of 11 questions separated into two
dimensions of fatigue—physical (items 1–7) and mental (items 8–11). This scale, scored
in “Likert” style, asked individuals to rate the severity of fatigue as 0, 1, 2 or 3 for a total
score of 0–33. The mean “Likert” score was 24.4 (SD 5.8) and 14.2 (SD 4.6) for physical and
mental fatigue, respectively [36].
The Fatigue Severity Scale (FSS) included nine statements that rated the severity of
fatigue symptoms on a scale of 1 to 7, based on how accurately it reflected their condition
during the previous week. A total score of 36 or more suggested fatigue [37].
The Fatigue Impact Scale (FIS) had 40 items, scored on a 5-point Likert scale (0–4),
providing a continuous scale of 0–160 with a higher score indicating greater fatigue [38].
2.3.2. Assessment of Cognitive Function
The Trail Making Test was used to evaluate various neuropsychological skills in-
cluding the executive functioning domain: working memory, visuospatial skills and task
switching [39]. The Trial Making Test Part A (TMT A) required the connection of dots
with numbers from 1 to 25 in sequential order to determine visual search and motor speed
skills. Part B of the test (TMT B) was used to test cognitive flexibility and executive control,
requiring the subjects to connect a number with a letter and then place them in ascending
order (e.g., 1-A, 2-B.) [40–43].
In the coding test—-an indicator of attention, working memory, motor speed, scan-
ning, associative learning and executive functions—-the subjects had to write down the
corresponding symbol to every digit in a consecutive manner as fast as possible. The result
recorded the number of digits left to be encoded after 60 and 120 s. If a subject was not
able to finish the task within 120 s, the task was interrupted [39,44].
2.3.3. Objective Assessment of Autonomic and Cardiovascular Function
The hemodynamic and left ventricular function parameters recorded were heart rate
(HR), mean blood pressure (mBP), stroke index (SI), cardiac index (CI), total peripheral
resistance index (TPRI), left ventricular ejection time (LVET), pre-ejection period (PEP),
left ventricular work index (LVWI) and the Heather index (HI). Autonomic parameters
included the ratio of low-frequency (LF) to high-frequency (HF) diastolic blood pressure of
the r to r interval (LF/HF). Baroreceptor sensitivity was measured in a beat-to beat manner
(Total BEI). Parameters were measured while supine after 5 min waiting for parameter
normalization with a dedicated Task Force Monitor (TFM, CNSystems, Medizintechnik,
Graz, Austria). The main area of TFM application was as an automated beat-to-beat analysis
of an electrocardiogram (ECG), impedance cardiography (ICG) and oscillometric and non-
invasive continuous blood pressure measurements (oscBP, contBP). TFM automatically
provided a power spectral analysis for HRV and BPV conducted using the adaptive
autoregressive model proposed by Bianchi et al. [45–47].
2.3.4. Arterial Stiffness Measurement
Vascular stiffness measurements were performed by the Arteriograph (TensioMed
Software v.1.9.9.2; TensioMed, Budapest, Hungary), which determined pulse wave velocity
(PWV) and augmentation index (Aix) as well as the aortic systolic blood pressure (sBP
aortic) by analysing the oscillometric pressure curves registered on the upper arm [48,49].
2.3.5. Body Composition Analysis
To measure body composition changes, a multifrequency, bioelectrical impedance ana-
lyzer (Tanita MC-180MA Body Composition Analyzer, Tanita, Manchester, UK) was applied.
All subjects were given a “normal” proprietary algorithm for the impedance measurement.
2.4. Statistical Analysis
Mean and standard deviation (±SD) values were presented, and the Shapiro–Wilk test
and histograms were used to test the assumption of normality. Levene’s test was used to test
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the assumption of homogeneity of variance, while. Mann–Whitney U or independent t-tests
were used to examine intergroup differences depending on meeting certain assumptions.
Effect size (r) was calculated for significance between group comparisons [50]. Spearman’s
rank correlation coefficient was used (Spearman’s ρ and p-value). Parametric methods were
not used because the majority of variables did not meet assumptions. The network analysis
was performed using Cytoscape software version 3.8.1 [51]. The variables were grouped
according to categories illustrated by node colour: cognitive function (green), fatigue scales
(blue), vascular function (magenta), cardiac muscle function (red) and autonomic nervous
system function (brown). The size of the dots next to the variable name is continuously
related to the number of statistically significant correlation coefficients with other variables
(assuming alpha = 0.05). Statistically significant correlations were only presented in form
of edges. The colours of the edges denoted the direction of correlation: blue indicated a
negative while red indicated a positive correlation. Edge width and intensity of colour
denoted the strength of the relationship. A Prefuse Force Directed Layout algorithm was
applied based on a non-negative strength correlation. A Cytoscape software tool was
used to analyse the networks. Based on a dyshomeostasis study [32], the values for the
number of edges per node, topological coefficient (relative measure for the extent of node
sharing with neighbors) neighbourhood connectivity (the average connectivity among all
neighbours of a node), stress (the number of shortest paths through each node), eccentricity
(maximum distance from v to any other node) and clustering coefficient (the degree to
which nodes in a graph tend to cluster together) were compared using the Mann–Whitney
U test. Differences between groups (CFS vs. control) before intervention and in delta value
(before and after WBC and SS) were analysed.
3. Results
3.1. Network Relationship before Intervention
Data obtained from 32 patients (26 females) with CFS and 18 control participants (10
females) were included. Baseline characteristics were similar between the two groups. As
shown in Table 1, differences were found in age, body composition and BMI.
Table 1. Comparison of CFS vs. controls before WBC and SS.
CFS (n = 32) Control (n = 18)
Parameter Mean ± SD Mean ± SD p-Value
Age (years) 36.72 ± 8.4 38.39 0.50
Body height (cm) 170.4 ± 8.3 172.6 ± 9.8 0.41
Body mass (kg) 72.2 ± 12.7 77.6 ± 20.3 0.27
BMI (kg/m2) 24.8 ± 3.6 25.8 ± 5.7 0.4
BMR (kcal) 6477.5 ± 1010.1 7029.1 ± 1624.2 0.15
FatP (%) 27.7 ± 7.5 26.4 ± 7.8 0.57
FatM (%) 20.4 ± 8.0 21.2 ± 10.5 0.75
FFM (kg) 51.8 ± 8.7 56.4 ± 12.9 0.14
VFat (level) 4.6 ± 2.4 5.9 ± 4.1 0.18
BoneM (kg) 2.6 ± 0.4 2.8 ± 0.6 0.16
BMI—body mass index, BMR—basal metabolic rate, FatP—body fat percentage, FatM—body fat mass, FFM—
free-fat mass, VFat—Visceral fat level, BoneM—bone mass.
The comparison of CFS patients with the controls before WBC and SS in respect of
other parameters is included in Table A1 (Appendix A). In the CFS group before WBC,
cognitive function was positively related to the central systolic blood pressure, namely, the
higher the sBP aortic the worse the cognitive function (Figure 4). In contrast, sBPaortic
had no significant edges in the control group (Figure 5). In the CFS group, fatigue scale
results were related to baroreceptor function, and baroreceptor function was related to
aortic stiffness, but no such edges were observed in the control group. On the other hand,
in the control group, fatigue scales results were related to cognitive function, but no such
connection was observed in the CFS patients. In addition, the LF/HF node was not related
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to other nodes in the CFS group. In contrast, LF/HF contained 3 edges connected with
parameters related to blood pressure regulation and cognitive function in the control group.
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second minute of coding test.
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Fatigue was not measured after WBC in the control group, so baseline values were 
included in the analysis. In the CFS group changes (delta) in fatigue scale results in re-
sponse to WBC were related to changes in baroreceptor function and aortic stiffness, while 
in the control group fatigue at baseline was related to changes in the autonomic nervous 
system (Figure 6). In the control group, changes (delta) in TMT A were related negatively 
to changes in fatigue scales (CFQ and FSS) (Figure 7). Stress and eccentricity of the net-
work were higher in the CFS group compared to control (50.9 ± 56.1 vs. 6.35 ± 8.72, p = 
0.002, r = 0.28 and 4.8 0.7 vs. 2.4 1, p = 0.0000004, r = 0.46, respectively). 
Figure 5. Network analysis in the control group before WBC and SS therapy. The variables were grouped according to
categories illustrated by colour of nodes: cognitive function (green), fatigue scales (blue), vascular system function (magenta)
cardiac muscle function (red), autonomic nervous system function (brown). The size of the dots next to the variable names
is continuously related to the number of statistically significant correlation coefficients with other variables. The colour of
the edges denotes the sign of correlation: blue indicates negative, while red indicates positive. Edge width and intensity
of colour denote strength of relationship. CFQ—Chronic Fatigue Scale, FSS—Fatigue Severity Scale, FIS—Fatigue Impact
Scale, HR—Hear Rate, SI—Stroke Index, HI—Heather index, PEP—Pre-ejection period, LVET—Left Ventricular Ejection
Time, CI Cardiac Index, LVWI—Left Ventricle Work Index, TPRI—Total Peripheral Resistance Index, mBP—Mean Blood
Pressure, PWVaorti —Aortic Pulse Wave Velocity, SBPaortic—ce tral systolic blood pressure, Tot l BEI—baroreceptor
effectiveness index, LF/HF—sympa hovagal balance, TMT A—Trial Making Test part A, TMT B—Tria Making Te t part B,
TMT B-A—Diff rence in result between TMT B and TMT A, Coding I—number of words left aft r first minute of coding
test; Coding II—number of words left after second minute of coding test.
Before WBC, eccentricity was lower in the CFS network compared to that of controls
(3.5 ± 1.4 vs. 4.7 ± 0.8, p = 0.01, r = −0.22). Topological and clustering coefficients were
higher in the CFS network than for the controls (0.67 ± 0.2 vs. 0.4 ± 0.2, p = 0.0004, r = 0.32
and 0.7 ± 0.3 vs. 0.4 ± 0.3, p = 0.01, r = 0.23, respectively.
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3.2. Network Relationships in Difference before and after Intervention (Delta Value)
Fatigue was not measured after WBC in the control group, so baseline values were
included in the analysis. In the CFS group changes (delta) in fatigue scale results in
response to WBC were related to changes in baroreceptor function and aortic stiffness,
while in the control group fatigue at baseline was related to changes in the autonomic
nervous system (Figure 6). In the control group, changes (delta) in TMT A were related
negatively to changes in fatigue scales (CFQ and FSS) (Figure 7). Stress and eccentricity of
the network were higher in the CFS group compared to control (50.9 ± 56.1 vs. 6.35 ± 8.72,
p = 0.002, r = 0.28 and 4.8 0.7 vs. 2.4 1, p = 0.0000004, r = 0.46, respectively).
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4. Discussion
A network analysis has been successfully applied in me icine [52] and physiology [53].
Such an approac might facilitate bridging t e knowledge gap concerni g the interaction
b tween physiolo ical systems [53]. This application of network analysis is considered
to be an emerging field, ot free from limitations. Ivanov et al. note that there is a
need to gather more data and to develop new methods of analysis that could be applied
to physiology [53].
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4.1. General Topography of Networks
In CFS patients, homeostasis disturbance was observed. Our exploratory analysis
showed differences in the network structure underlying the relationships between cog-
nitive function, fatigue, cardiovascular and autonomic function in both general topology
and amongst specific nodes and their interactions. In part we confirmed the results of a
previous study, where a disturbance in autonomic and cardiovascular homeostasis and
glucose metabolism were noted in the CFS patients [32]. A similar observation on general
topography in comparison to the previous study was noted. Before WBC and stretching,
the autonomic network in the CFS patients showed a more uneven distribution of infor-
mation [32]. In the current study, before WBC and stretching, nodes illustrating cognitive
function test results were only connected to nodes in the same category, while the central
systolic blood pressure was the only noted connection outside of this group. In comparison,
both the current and the previous study found that networks in the control group were
distributed in a more regular and balanced fashion. Clark et al. noted that this was in line
with theoretical computational models [54,55] and the results of studies based on data from
human studies [56]. In the previous study, stroke volume was one of three centres crucial
in the CFS group network [32]. Accordingly, in the current study, the stroke index was also
a node characterized by higher connectivity compared to other nodes, both before WBC
and SS and in the differences between before and after. In the current study, a change in
SI in response to WBC and SS was related to changes in baroreceptors function, while no
such connection was observed in the control group.
4.2. Network before WBC with Static Stretching (SS) Program in CFS vs. Healthy Controls
In the CFS group before WBC, cognitive function was positively related to central
systolic blood pressure, namely, the higher the sBP aortic the worse the cognitive function.
In contrast, sBPaortic had no significant edges in the control group. Negative correlation
between aortic stiffness and cognitive function in the CFS group was in accordance with
previous results where higher aortic stiffness was related to worse cognitive function in
older people [57]. Increased aortic stiffness could be related to higher flow pulsatility and
an excessive pulsatile load on the heart, as well as to microvascular lesions in organs with
high metabolic demands, such as the brain [58].
In the CFS group, fatigue levels related to baroreceptor function, and baroreceptor
function was, in turn, related to aortic stiffness, while no such edges were observed in the
control group. Orthostatic intolerance is one of the hallmark symptoms of CFS [59]. In
previous studies, lower ambulatory blood pressure had been observed in CFS patients
compared to healthy controls [60] as had disturbance in blood pressure control [61,62].
Baroreceptor reflex sensitivity was disturbed to a greater degree in severe CFS patients
than in those with less severity [63]. In a recent study of fibromyalgia patients, fatigue was
related to baroreflex dysfunction [64].
In addition, in the CFS group, sympathovagal balance was absent in the network,
compared to the control group, where it contained 3 edges connecting with parameters
related to blood pressure regulation and cognitive function. Observation in the healthy
controls group was in line with previous studies exploring the relationship between the
autonomic nervous system and cognitive function [30,31].
The lack of a significant relationship between fatigue severity and cognitive function
was a surprise, but such a relationship was observed in the control group. Brain fog
includes a generally slower response speed for tasks that require simple and complex
information processing and a lesser ability to focus on a task [26]. Studies also confirm that
cognitive disturbance in ME/CFS patients is restricted to a decrease in basic processing
speed and is not related to depression severity [27,29]. However, brain fog intensity might
presumably not be directly related to fatigue intensity. Further studies should be done to
examine the nature of the relationship between these specific symptoms frequently seen in
CFS patients.
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4.3. Dynamics of the Network of WBC with Static Stretching (SS) Program in CFS vs.
Healthy Controls
In the CFS group, changes in fatigue in response to WBC and SS were related to
changes in baroreceptor function and aortic stiffness, while in the control group fatigue
during baseline was related to changes in autonomic parameters. Moreover, changes in
cognitive function were related to changes in the LF/HF ratio, namely the sympathovagal
balance and to the results from one of the fatigue scales (FIS). Further studies should
determine if a decrease in brain fog intensity is related to therapies that improve autonomic
function and reduce fatigue. A previous study of multiple sclerosis patients showed that
WBC might reduce fatigue [7], while Rymaszewska et al. showed that it might lead to
improvement in some domains of cognitive function [6]. Moreover, stretching can reduce
fatigue in call-centre workers [65] and in high school students [66]. A stretching training
program might induce a variety of physiological adaptations [20]. HR increase in response
to stretching is transient: a rapid rise of 4–5 beats/minute was noted and then a return
to baseline occurs within several seconds [67–69]. Moreover, the authors of a review on
stretching effects noted an increase in parasympathetic and a decrease in sympathetic
activity after subjects exercised all the large muscle groups, but rather unequivocal effects
for aortic stiffness [20]. Presumably, cognitive function improvement might be related to
autonomic nervous system changes and fatigue reduction. Further studies should examine
the influence of different therapies on brain fog and its underlying mechanism in CFS.
4.4. Study Limitations
The same intervention (WBC and SS) was applied to both the CFS and healthy control
group. In further studies, the effects of WBC should be compared to SS solely and in
combination. In the current study healthy controls were not age-matched to CFS groups.
However, no significant differences in age or BMI and body composition were found. One
of the study limitations was that the results were not adjusted for multiple corrections. The
Fukuda criteria for CFS were used [70–72], but consideration might be given to combining
Fukuda with others: for instance, the International Consensus Criteria [72].
4.5. Clinical Implications
Our study was the first to show the effects of whole-body cryotherapy with a static
stretching exercise on the network relationship between fatigue, cognitive function, the
cardiovascular and autonomic nervous systems in a group of patients with Chronic Fatigue
Syndrome. Our exploratory analysis showed that a difference in the network structure was
observed both before the intervention and in the difference before and after 10 sessions of
WBC with static stretching. Further studies involving different orders of time and dose
response to WBC are still required to understand the mechanisms involved in fatigue
reduction for it to be safely prescribed and more widely used in CFS patient management.
In addition, certain stressors such as physical exercise or cognitive effort might induce
PEM in CFS patients [73]. For example, in our previous study based on an aerobic activity
program, 35 of 69 patients were unable to tolerate the intervention [74]. In the above study,
all the CFS patients who started the intervention completed it. Further studies should
consider whether PEM can be induced by any type of stressor or whether it is more related
to certain types of activity, such as strenuous physical exercise. In addition, the effects of
WBC and a stretching program should be examined with patients experiencing different
intensities of symptoms.
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Appendix A
Table A1. Comparison of CFS vs. controls before WBC and SS.
CFS (n = 32) Control (n = 18)
Parameter Mean ± SD Mean ± SD p-Value
TMT A (s) 23.03 ± 6.2 24.50 ± 7.6 0.5
TMT B (s) 50.19 ± 13.9 59.72 ± 25.0 0.09
TMT B-A (s) 27.16 ± 11.4 35.22 ± 23.7 0.32
Coding 1 min (symbols_to_go) 52.81 ± 9.5 55.17 ± 7.3 0.35
Coding 2 min (symbols_to_go) 12.68 ± 11.5 15.11 ± 11.1 0.48
CFQ (points) 22.06 ± 4.5 12.50 ± 3.3 <0.001
FIS (points) 54.47 ± 24.2 22.72 ± 19.5 <0.001
FSS (points) 45.41 ± 8.7 30.00 ± 11.4 <0.001
PWV aortic (m/s) 8.41 ± 2.1 8.06 ± 1.6 0.89
Aix aortic (%) 28.72 ± 12.4 22.45 ± 11.4 0.08
sBP aortic (mmHg) 135.06 ± 17.8 128.91 ± 19.0 0.25
HR (n/1) 69.98 ± 8.8 75.56 ± 10.5 0.05
mBP (mmHg) 95.80 ± 8.9 96.41 ± 11.0 0.83
SI (mL/m2) 54.22 ± 12.6 48.97 ± 10.3 0.14
CI (L/min/m2) 3.76 ± 0.9 3.67 ± 0.9 0.71
TPRI (dyne*s*m2/cm5) 2127.60 ± 666.2 2167.97 ± 579.0 0.59
LVWI (mmHg*L/(min*m2)) 4.78 ± 1.1 4.68 ± 1.0 0.77
LVET (ms) 316.79 ± 12.0 305.36 ± 16.1 0.01
PEP (ms) 110.07 ± 14.2 104.60 ± 12.7 0.18
HI (1/s2) 0.37 ± 0.1 0.33 ± 0.1 0.27
LF/HF 1.60 ± 1.9 2.48 ± 1.7 0.002
Total BEI (%) 67.28 ± 11.6 65.95 ± 22.8 0.79
CFQ—Chronic Fatigue Scale, FSS—Fatigue Severity Scale, FIS—Fatigue Impact Scale, HR—Hear Rate, SI
—Stroke Index, HI—Heather index, PEP—Preejection period, LVET—Left Ventricular Ejection Time, CI—Cardiac
Index, LVWI—Left Ventricle Work Index, TPRI—Total Peripheral Resistance Index, mBP—Mean Blood Pressure,
PWVaortic—Aortic Pulse Wave Velocity, SBPaortic—central systolic blood pressure, Total BEI—baroreceptor
effectiveness index, LF/HF—sympathovagal balance, TMT A—Trial Making Test part A, TMT B—Trial Making
Test part B, TMT B-A—Difference in result between TMT B and TMT A, Coding I—min-number of words left
after 1st minute of coding test, Coding II—min-number of words left after 2nd minute of coding test.
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on the rheological parameters of blood in older women with spondyloarthrosis. Clin. Hemorheol. Microcirc. 2017, 66, 187–195.
[CrossRef] [PubMed]
3. Banfi, G.; Lombardi, G.; Colombini, A.; Melegati, G.; Banfi, P.G. Whole-Body Cryotherapy in Athletes. Sports Med. 2010, 40,
509–517. [CrossRef]
4. Vitenet, M.; Tubez, F.; Marreiro, A.; Polidori, G.; Taiar, R.; Legrand, F.; Boyer, F. Effect of whole body cryotherapy interventions
on health-related quality of life in fibromyalgia patients: A randomized controlled trial. Complement. Ther. Med. 2018, 36, 6–8.
[CrossRef]
5. Zalewski, P.; Bitner, A.; Słomko, J.; Szrajda, J.; Klawe, J.J.; Tafil-Klawe, M.; Newton, J.L. Whole-body cryostimulation increases
parasympathetic outflow and decreases core body temperature. J. Therm. Biol. 2014, 45, 75–80. [CrossRef] [PubMed]
J. Clin. Med. 2021, 10, 2795 14 of 16
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Stretching Warm-up on Repeated-Sprint Performance in Female Handball Players. J. Hum. Kinet. 2020, 72, 161–172. [CrossRef]
36. Jackson, G. The Chalder Fatigue Scale (CFQ 11). Occup. Med. 2015, 65, 86. [CrossRef]
37. Fisk, J.D.; Ritvo, P.G.; Ross, L.; Haase, D.A.; Marrie, T.J.; Schlech, W.F. Measuring the Functional Impact of Fatigue: Initial
Validation of the Fatigue Impact Scale. Clin. Infect. Dis. 1994, 18, S79–S83. [CrossRef]
38. Krupp, L.B.; LaRocca, N.G.; Muir-Nash, J.; Steinberg, A.D. The Fatigue Severity Scale: Application to Patients with Multiple
Sclerosis and Systemic Lupus Erythematosus. Arch. Neurol. 1989, 46, 1121–1123. [CrossRef] [PubMed]
39. Lezak, M.D.; Howieson, D.B.; Loring, D.W. Neuropsychological Assessment; Oxford University Press: New York, NY, USA, 2004; pp.
368–370, ISBN 978-0-19-511121-7.
40. Reitan, R.M. Validity of the Trail Making Test as an Indicator of Organic Brain Damage. Percept. Mot. Ski. 1958, 8, 271–276.
[CrossRef]
41. Crowe, S.F. The differential contribution of mental tracking, cognitive flexibility, visual search, and motor speed to performance
on parts A and B of the Trail Making Test. J. Clin. Psychol. 1998, 54, 585–591. [CrossRef]
42. Arbuthnott, K.; Frank, J. Trail Making Test, Part B as a Measure of Executive Control: Validation Using a Set-Switching Paradigm.
J. Clin. Exp. Neuropsychol. 2000, 22, 518–528. [CrossRef]
43. Kortte, K.B.; Horner, M.D.; Windham, W.K. The Trail Making Test, Part B: Cognitive Flexibility or Ability to Maintain Set? Appl.
Neuropsychol. 2002, 9, 106–109. [CrossRef] [PubMed]
44. Jaeger, J. Digit Symbol Substitution Test. J. Clin. Psychopharmacol. 2018, 38, 513–519. [CrossRef]
45. Bianchi, A.M.; Mainardi, L.T.; Meloni, C.; Chierchia, S.; Cerutt, S. Continuous monitoring of the sympatho-vagal balancethrough
spectral analysis. IEEE Eng. Med. Biol. Mag. 1997, 16, 64–73. [CrossRef]
46. Fortin, J.; Klinger, T.; Wagner, C.; Sterner, H.; Madritsch, C.; Grullenberger, R. The task force monitor–a non-invasive beat-to-
beat monitor for hemodynamic and autonomic function of the human body. In Proceedings of the 20th Annual International
Conference of the IEEE Engineering in Medicine and Biology Society, Austin, TX, USA, 1 November 1998.
47. Fortin, J.; Marte, W.; Grüllenberger, R.; Hacker, A.; Habenbacher, W.; Heller, A.; Wagner, C.; Wach, P.; Skrabal, F. Continuous
non-invasive blood pressure monitoring using concentrically interlocking control loops. Comput. Biol. Med. 2006, 36, 941–957.
[CrossRef]
48. Ring, M.; Eriksson, M.J.; Zierath, J.R.; Caidahl, K. Arterial stiffness estimation in healthy subjects: A validation of oscillometric
(Arteriograph) and tonometric (SphygmoCor) techniques. Hypertens. Res. 2014, 37, 999–1007. [CrossRef]
49. Baulmann, J.; Schilings, U.; Rickert, S.; Uen, S.; Dusing, R.; Cziraki, A.; Nickenig, G.; Mengden, T. A new oscillometric method for
assessment of arterial stiffness: Comparison with tonometric and piezo-electronic methods. J. Hypertens. 2008, 26, 3. [CrossRef]
50. Field, A. Discovering Statistics Using SPSS; Sage Publications: London, UK, 2009; p. 550.
51. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A
Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003, 13, 2498–2504. [CrossRef]
52. Zanzoni, A.; Soler-López, M.; Aloy, P. A network medicine approach to human disease. FEBS Lett. 2009, 583, 1759–1765.
[CrossRef] [PubMed]
53. Ivanov, P.C.; Liu, K.K.L.; Bartsch, R. Focus on the emerging new fields of network physiology and network medicine. New J. Phys.
2016, 18. [CrossRef] [PubMed]
54. Hammer, P.E.; Saul, J.P. Resonance in a mathematical model of baroreflex control: Arterial blood pressure waves accompanying
postural stress. Am. J. Physiol. Integr. Comp. Physiol. 2005, 288, R1637–R1648. [CrossRef]
55. Liang, F.; Liu, H. Simulation of Hemodynamic Responses to the Valsalva Maneuver: An Integrative Computational Model of the
Cardiovascular System and the Autonomic Nervous System. J. Physiol. Sci. 2006, 56, 45–65. [CrossRef] [PubMed]
56. Vieluf, S.; Hasija, T.; Jakobsmeyer, R.; Schreier, P.J.; Reinsberger, C. Exercise-Induced Changes of Multimodal Interactions Within
the Autonomic Nervous Network. Front. Physiol. 2019, 10, 240. [CrossRef]
57. Rensma, S.P.; Stehouwer, C.D.; Van Boxtel, M.P.; Houben, A.J.; Berendschot, T.T.; Jansen, J.F.; Schalkwijk, C.G.; Verhey, F.R.;
Kroon, A.A.; Henry, R.M.; et al. Associations of Arterial Stiffness with Cognitive Performance, and the Role of Microvascular
Dysfunction. Hypertension 2020, 75, 1607–1614. [CrossRef]
58. Mitchell, G.F. Aortic stiffness, pressure and flow pulsatility, and target organ damage. J. Appl. Physiol. 2018, 125, 1871–1880.
[CrossRef] [PubMed]
59. Garner, R.; Baraniuk, J.N. Orthostatic intolerance in chronic fatigue syndrome. J. Transl. Med. 2019, 17, 185. [CrossRef] [PubMed]
60. Newton, J.L.; Sheth, A.; Shin, J.; Pairman, J.; Wilton, K.; Burt, J.A.; Jones, D.E.J. Lower Ambulatory Blood Pressure in Chronic
Fatigue Syndrome. Psychosom. Med. 2009, 71, 361–365. [CrossRef] [PubMed]
61. Wyller, V.B.; Barbieri, R.; Saul, J.P. Blood pressure variability and closed-loop baroreflex assessment in adolescent chronic fatigue
syndrome during supine rest and orthostatic stress. Graefe Arch. Clin. Exp. Ophthalmol. 2010, 111, 497–507. [CrossRef] [PubMed]
62. Frith, J.; Zalewski, P.; Klawe, J.J.; Pairman, J.; Bitner, A.; Tafil-Klawe, M.; Newton, J.L. Impaired blood pressure variability in
chronic fatigue syndrome–a potential biomarker. QJM Int. J. Med. 2012, 105, 831–838. [CrossRef]
J. Clin. Med. 2021, 10, 2795 16 of 16
63. Peckerman, A.; LaManca, J.J.; Qureishi, B.; Dahl, K.A.; Golfetti, R.; Yamamoto, Y.; Natelson, B.H. Baroreceptor Reflex and
Integrative Stress Responses in Chronic Fatigue Syndrome. Psychosom. Med. 2003, 65, 889–895. [CrossRef]
64. del Paso, G.A.R.; Contreras-Merino, A.M.; de la Coba, P.; Duschek, S. The cardiac, vasomotor, and myocardial branches of
the baroreflex in fibromyalgia: Associations with pain, affective impairments, sleep problems, and fatigue. Psychophysiology
2021, 58, e13800. [CrossRef]
65. Lacaze, D.H.D.C.; Sacco, I.D.C.N.; Rocha, L.E.; Pereira, C.A.D.B.; Casarotto, R.A. Stretching and joint mobilization exercises
reduce call-center operators’ musculoskeletal discomfort and fatigue. Clinics 2010, 65, 657–662. [CrossRef] [PubMed]
66. Kim, J.S.; Lee, S.; Kim, M.S. The Effect of Stretching on Fatigue and Concentration in High School Students. Child Health Nurs. Res.
2006, 12, 196–203.
67. Gladwell, V.F.; Coote, J.H. Heart rate at the onset of muscle contraction and during passive muscle stretch in humans: A role for
mechanoreceptors. J. Physiol. 2002, 540, 1095–1102. [CrossRef]
68. Gladwell, V.F.; Fletcher, J.; Patel, N.; Elvidge, L.J.; Lloyd, D.; Chowdhary, S.; Coote, J.H. The influence of small fibre muscle
mechanoreceptors on the cardiac vagus in humans. J. Physiol. 2005, 567, 713–721. [CrossRef]
69. Cui, J.; Blaha, C.; Moradkhan, R.; Gray, K.S.; Sinoway, L.I. Muscle sympathetic nerve activity responses to dynamic passive
muscle stretch in humans. J. Physiol. 2006, 576, 625–634. [CrossRef]
70. Słomko, J.; Newton, J.L.; Kujawski, S.; Tafil-Klawe, M.; Klawe, J.; Staines, D.; Marshall-Gradisnik, S.; Zalewski, P. Prevalence and
characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: A cross-sectional study. BMJ Open
2019, 9, e023955. [CrossRef]
71. Eguchi, A.; Fukuda, S.; Kuratsune, H.; Nojima, J.; Nakatomi, Y.; Watanabe, Y.; Feldstein, A.E. Identification of actin network pro-
teins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic
fatigue syndrome. Brain Behav. Immun. 2020, 84, 106–114. [CrossRef] [PubMed]
72. Kitami, T.; Fukuda, S.; Kato, T.; Yamaguti, K.; Nakatomi, Y.; Yamano, E.; Kataoka, Y.; Mizuno, K.; Tsuboi, Y.; Kogo, Y.; et al.
Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population. Sci. Rep. 2020, 10, 19933.
[CrossRef] [PubMed]
73. Chu, L.; Valencia, I.J.; Garvert, D.W.; Montoya, J.G. Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic
fatigue syndrome: A patient-centered, cross-sectional survey. PLoS ONE 2018, 13, e0197811. [CrossRef] [PubMed]
74. Kujawski, S.; Cossington, J.; Słomko, J.; Dawes, H.; Strong, J.W.; Estevez-Lopez, F.; Murovska, M.; Newton, J.L.; Hodges, L.;
Zalewski, P. Prediction of Discontinuation of Structured Exercise Programme in Chronic Fatigue Syndrome Patients. J. Clin. Med.
2020, 9, 3436. [CrossRef] [PubMed]
